Expertise in
12
conditions

Jeffrey S. Healey

Hamilton, ON, CA 
Expertise in
12
conditions
Hamilton, ON, CA 
OverviewLocationsClinical Research

Overview

Jeffrey Healey practices in Hamilton, Canada. Healey is highly rated in 12 conditions, according to our data. Their top areas of expertise are Atrial Fibrillation, Cardiac Arrest, Arterial Embolism, Cardiac Ablation, and Transcatheter Aortic Valve Replacement (TAVR).

Their clinical research consists of co-authoring 140 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Hamilton, ON, Canada
Other Locations
Canada
Vancouver, BC, Canada
Halifax, NS, Canada
Calgary, AB, Canada
Montreal, QC, Canada
Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Enrollment Status: Completed
Publish Date: May 30, 2025
Intervention Type: Device, Other
Study Phase: Phase 3
Multi-Centre, Open-Label, Safety Study of Etripamil Nasal Spray in Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia The NODE-302 Trial (Extension of NODE-301)
Multi-Centre, Open-Label, Safety Study of Etripamil Nasal Spray in Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia The NODE-302 Trial (Extension of NODE-301)
Enrollment Status: Terminated
Publish Date: November 05, 2024
Intervention Type: Drug, Device
Study Phase: Phase 3
Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of Etripamil Nasal Spray for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia. NODE 301 and RAPID Studies
Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of Etripamil Nasal Spray for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia. NODE 301 and RAPID Studies
Enrollment Status: Terminated
Publish Date: July 12, 2024
Intervention Type: Drug
Study Drug: Etripamil
Study Phase: Phase 3
View 2 Less Clinical Trials

140 Total Publications

Device-Detected Atrial Fibrillation in Patients With and Without Cryptogenic Ischemia: The ANTARCTICA Pooled Analysis.
Device-Detected Atrial Fibrillation in Patients With and Without Cryptogenic Ischemia: The ANTARCTICA Pooled Analysis.
Journal: Stroke
Published: August 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Healey's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 16 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile